Liminal BioSciences is a development-stage biopharmaceutical company based in Rockville, MD, specializing in the treatment of metabolic, fibrotic, and inflammatory diseases. With a strong focus on drug discovery and a data-driven approach, they are dedicated to developing distinctive novel small molecule therapeutics.
Driven by their expertise in small molecules, Liminal BioSciences boasts a robust product pipeline that includes potential first best-in-class drug candidates, positioning them at the forefront of innovation in the biopharmaceutical industry.
Generated from the website